# Immune pathways and prenatal/perinatal environmental exposures contribute to epigenetic gestational age prediction and acceleration

**Authors:** Amy A. Eapen, Ian M. Loveless, Mingming Pan, Xiaoyu Liang, Audrey Urquhart, Jennifer K. Straughen, Andrea E. Cassidy-Bushrow, Alexandra R. Sitarik, Neil Simmerman, Emma Thompson, Leah Kottyan, Carole Ober, Christine C. Johnson, Edward Zoratti, Albert M. Levin

PMC · DOI: 10.1080/15592294.2025.2610521 · Epigenetics · 2026-01-20

## TL;DR

This study explores how immune pathways and prenatal environmental factors influence epigenetic age prediction in newborns.

## Contribution

The study introduces a new DNA methylation array focused on asthma and allergy loci and evaluates its role in gestational age prediction.

## Key findings

- 2,435 CpG sites were found to be associated with chronological gestational age.
- HLA class II locus CpGs showed the strongest association with gestational age.
- Immune-related pathways like Th1/Th2 activation and B-cell development were enriched in GA-associated CpGs.

## Abstract

DNA methylation (DNAm), capturing chronological gestational age (GA) and epigenetic gestational age acceleration (EGAA), can be modified by environmental exposures. The Asthma&Allergy array is a new DNAm array developed with content focused on asthma and allergy loci. The association between content on the Asthma&Allergy array and chronological GA and EGAA has not been evaluated alone or in the context of prenatal/perinatal exposures. We performed an epigenome wide association study (EWAS) chronological GA at single CpG sites and regions in cord blood from 391 newborn children from a Detroit-based birth cohort. We further constructed a multi-CpG site methylation model to predict chronological GA. Also, associations between prenatal/perinatal environmental factors with GA, epigenetic gestational age (EGA), and EGAA were assessed. We identified 2,435 CpG sites associated with chronological GA, and CpGs within the HLA class II locus (HLA-DRB1, HLA-DQB1, HLA-DRB6) were among the most significantly associated with chronological GA. Our multi-CpG site model attained higher predictive accuracy (R2 = 0.88) comparable to other published methods. Using genes implicated in region-based analyses (n = 395 regions), the pathways most significantly enriched with chronological GA-associated CpGs included T helper 1(Th1) and 2(Th2) activation, B-cell development, and IL-10 signaling, which were also enriched in at least one of the other published epigenetic GA clocks. In multi-exposure models, infant’s first-born status and maternal parity were associated with EGAA. Our findings highlight enrichment for T cell modulated pathways and antigen presentation as biological processes associated with chronological GA, as well as prenatal/perinatal factors that may affect EGAA.

## Linked entities

- **Genes:** HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123], HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119], HLA-DRB6 (major histocompatibility complex, class II, DR beta 6 (pseudogene)) [NCBI Gene 3128]
- **Diseases:** asthma (MONDO:0004979), allergy (MONDO:0005271)

## Full-text entities

- **Genes:** EID3 (EP300 interacting inhibitor of differentiation 3) [NCBI Gene 493861] {aka NS4EB, NSE4B, NSMCE4B}, FBXW2 (F-box and WD repeat domain containing 2) [NCBI Gene 26190] {aka FBW2, Fwd2, Md6}, IKZF5 (IKAROS family zinc finger 5) [NCBI Gene 64376] {aka PEGASUS, THC7, ZNFN1A5}, MIR4706 (microRNA 4706) [NCBI Gene 100616490] {aka mir-4706}, PRSS16 (serine protease 16) [NCBI Gene 10279] {aka TSSP}, HLA-DQB1 (major histocompatibility complex, class II, DQ beta 1) [NCBI Gene 3119] {aka CELIAC1, HLA-DQB, IDDM1}, CD247 (CD247 molecule) [NCBI Gene 919] {aka CD3-ZETA, CD3H, CD3Q, CD3Z, CD3ZETA, IMD25}, HLA-DQB2 (major histocompatibility complex, class II, DQ beta 2) [NCBI Gene 3120] {aka DQB2, HLA-DQB1, HLA-DXB}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, LYSMD1 (LysM domain containing 1) [NCBI Gene 388695] {aka SB145}, NR1H2 (nuclear receptor subfamily 1 group H member 2) [NCBI Gene 7376] {aka LXR-b, LXRB, NER, NER-I, RIP15, UNR}, HLA-DMB (major histocompatibility complex, class II, DM beta) [NCBI Gene 3109] {aka D6S221E, RING7}, HLA-DMA (major histocompatibility complex, class II, DM alpha) [NCBI Gene 3108] {aka D6S222E, DMA, HLADM, RING6}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, HLA-DRB6 (major histocompatibility complex, class II, DR beta 6 (pseudogene)) [NCBI Gene 3128], HLA-DRB1 (major histocompatibility complex, class II, DR beta 1) [NCBI Gene 3123] {aka DRB1, HLA-DR1B, HLA-DRB, SS1}, NR1H3 (nuclear receptor subfamily 1 group H member 3) [NCBI Gene 10062] {aka LXR-a, LXRA, RLD-1}, SCARF2 (scavenger receptor class F member 2) [NCBI Gene 91179] {aka NSR1, SREC-II, SREC2, SRECRP-1, VDEGS}
- **Diseases:** Allergy (MESH:D004342), inflammatory (MESH:D007249), cardiometabolic disorders (MESH:D024821), EGA (MESH:D016640), preterm births (MESH:D047928), immune-related diseases (MESH:D007154), tumor (MESH:D009369), developmental delay (MESH:D002658), Asthma (MESH:D001249), obesity (MESH:D009765), pre-eclampsia (MESH:D011225)
- **Chemicals:** EGA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Nicotiana tabacum (American tobacco, species) [taxon 4097]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12826722/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12826722/full.md

## References

54 references — full list in the complete paper: https://tomesphere.com/paper/PMC12826722/full.md

---
Source: https://tomesphere.com/paper/PMC12826722